NCT01895205View on ClinicalTrials.gov

Treatment of Women After Severe Postpartum Haemorrhage

PHASE3CompletedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Severe Postpartum Haemorrhage

Interventions

DRUG

Iron isomaltoside 1000

DRUG

Red blood cell transfusion

Trial Locations (1)

Unknown

Copenhagen

Sponsors

Lead Sponsor

Pharmacosmos A/S

Collaborators (1)

All Listed Sponsors

collaborator

BioStata

INDUSTRY

lead

Pharmacosmos A/S

INDUSTRY

NCT01895205 - Treatment of Women After Severe Postpartum Haemorrhage | Biotech Hunter | Biotech Hunter